Search
Patexia Research
Case number IPR2023-01444

Biocon Biologics Inc. et al. v. Janssen Biotech, Inc. > Documents

Date Field Doc. No.PartyDescription
Apr 15, 2024 14 board Notice: refund approved Download
Apr 11, 2024 13 petitioner Petitioner's Request for Refund of Post-Institution Fees Download
Mar 4, 2024 12 board Termination Decision: Pre-DI settlement Download
Mar 1, 2024 0 petitioner Joint Motion to Terminate Proceeding Download
Mar 1, 2024 11 petitioner Joint Motion to Treat Settlement Agreement as Business Confidential Download
Mar 1, 2024 10 petitioner Joint Motion to Terminate Proceeding Download
Feb 28, 2024 3001 board Exhibit 3001 Download
Jan 18, 2024 9 patent_owner Patent Owner's Updated Mandatory Notices Download
Jan 16, 2024 8 board Download
Jan 8, 2024 7 patent_owner Patent Owner's Exhibit List Download
Jan 8, 2024 6 patent_owner Patent Owner's Unopposed Motion for Pro Hac Vice Admission of Roger J. Chin Download
Jan 8, 2024 2001 patent_owner Ex. 2001 Decl. of Roger J. Chin iso PHV Admission Download
Dec 13, 2023 5 patent_owner Patent Owner's Mandatory Notices Download
Dec 13, 2023 4 patent_owner Notice : Power of Attorney Download
Nov 28, 2023 3 board Notice: Notice filing date accorded Download
Nov 22, 2023 1015 petitioner EX-1015 - Pedersen et al., Inflammatory pathways of importance for... Download
Nov 22, 2023 1016 petitioner EX-1016 - Coskun et al., Novel Targeted Therapies for Inflammatory Bowel... Download
Nov 22, 2023 1017 petitioner EX-1017 - Sandborn et al., A Randomized Trial of Ustekinumab... Download
Nov 22, 2023 1018 petitioner EX-1018 - U.S. Patent No. 6,902,734 B2 issued to Giles-Komar et al. Download
Nov 22, 2023 1019 petitioner EX-1019 - U.S. Patent No. 7,166,285 B2 issued to Giles-Komar et al. Download
Nov 22, 2023 1020 petitioner EX-1020c -Application for Extension re U.S. Patent 6,902,734 (part 3 of 3) Download
Nov 22, 2023 1020 petitioner EX-1020b -Application for Extension re U.S. Patent 6,902,734 (part 2 of 3) Download
Nov 22, 2023 1020 petitioner EX-1020a -Application for Extension re U.S. Patent 6,902,734 (part 1 of 3) Download
Nov 22, 2023 1021 petitioner EX-1021 -Application for Extension of Patent Term for U.S. Patent 7,166,285 Download
Nov 22, 2023 1022 petitioner Download
Nov 22, 2023 1023 petitioner EX-1023 - Webarchive screenshots of www.pmda.go.jp/english/index.html Download
Nov 22, 2023 1024 petitioner EX-1024 - Stelara Prescribing Information (Sept. 2009) Download
Nov 22, 2023 1025 petitioner Download
Nov 22, 2023 1026 petitioner EX-1026 - Feagan et al., Ustekinumab as Induction and Maintenance Therapy. Download
Nov 22, 2023 1027 petitioner EX-1027 - Janssen R & D NCT02407236 Clinical Protocol (Apr. 20, 2016) Download
Nov 22, 2023 1028 petitioner EX-1028 - Affidavit of Nathaniel E Frank-White Download
Nov 22, 2023 1029 petitioner EX-1029 -Ulcerative Colitis: Clinical Trial Endpoints Guidance for Industry Download
Nov 22, 2023 1030 petitioner EX-1030 -Field Trials of Health Interventions: A Toolbox, 2015, pp. 200-201 Download
Nov 22, 2023 1031 petitioner EX-1031 - Sands et al., Ustekinumab as Induction and Maintenance Therapy... Download
Nov 22, 2023 1032 petitioner EX-1032 - Janssen Announces U.S. FDA Approval of STELARA (ustekinumab)... Download
Nov 22, 2023 1033 petitioner EX-1033 - Tarr et al., Superheroes in autoimmune warfare: Biologic... Download
Nov 22, 2023 1034 petitioner EX-1034 - Kolios et al., Paradoxical ulcerative colitis during adalimumab.. Download
Nov 22, 2023 1035 petitioner EX-1035 - Afonso et al., CP-202 Ustekinumab treatment in refractory... Download
Nov 22, 2023 1036 petitioner EX-1036a - Excerpts from U.S. Patent 10,961,307 file history (1 of 2) Download
Nov 22, 2023 1036 petitioner EX-1036b - Excerpts from U.S. Patent 10,961,307 file history (2 of 2) Download
Nov 22, 2023 1038 petitioner EX-1038 - FDA Approves STELARA (Ustekinumab) for Treatment... (9/26/2016) Download
Nov 22, 2023 1041 petitioner EX-1041 - American of College of Rheumatology: Ustekinumab (Stelara) (2018) Download
Nov 22, 2023 1042 petitioner Download
Nov 22, 2023 1043 petitioner EX-1043 - Dhanda et al., Can Endoscopy Be Avoided in the Assessment... Download
Nov 22, 2023 1 petitioner Notice : Petitioner's Power of Attorney Download
Nov 22, 2023 1045 petitioner EX-1045 - Outcome Measure Considerations for Clinical Trials Reporting... Download
Nov 22, 2023 1046 petitioner EX-1046 - History of Changes for Study: NCT02407236, ClinicalTrials.gov Download
Nov 22, 2023 1047 petitioner EX-1047 - History of Changes for Study 2: NCT02407236, ClinicalTrials.gov Download
Nov 22, 2023 1048 petitioner EX-1048 - Kim et al., Correlation between Histological Activity... Download
Nov 22, 2023 1049 petitioner EX-1049a -U.S. Patent Application Publication 2020/0262908 A1 (part 1 of 2) Download
Nov 22, 2023 1049 petitioner EX-1049b -U.S. Patent Application Publication 2020/0262908 A1 (part 2 of 2) Download
Nov 22, 2023 1050 petitioner EX-1050 - Pithadia & Jain, Treatment of inflammatory bowel disease (IBD) Download
Nov 22, 2023 1051 petitioner EX-1051 - Higgins et al., Is Endoscopy Necessary for the Measurement... Download
Nov 22, 2023 1052 petitioner Download
Nov 22, 2023 1052 petitioner Download
Nov 22, 2023 1053 petitioner Download
Nov 22, 2023 1054 petitioner EX-1054 - History of Changes for Study: NCT02407236, ClinicalTrials.gov Download
Nov 22, 2023 1055 petitioner EX-1055 - Stelara, European Medicines Agency Download
Nov 22, 2023 1056 petitioner EX-1056 - Nakov et al., Correlation between Ulcerative Colitis Endoscopic Download
Nov 22, 2023 1060 petitioner EX-1060 - A Safety and Efficacy Study for Infliximab (Remicade) in Patients Download
Nov 22, 2023 1061 petitioner EX-1061 - Efficacy and Safety of Adalimumab in Subjects With Moderately... Download
Nov 22, 2023 1062 petitioner EX-1062 - Study of Vedolizumab (MLN0002) in Patients With Moderate to... Download
Nov 22, 2023 1063 petitioner EX-1063 - Sequence published with WO 2015/119841 A1 issued to Zuniga et al. Download
Nov 22, 2023 1064 petitioner EX-1064 - A Study to Evaluate the Safety and Efficacy of Ustekinumab... Download
Nov 22, 2023 1065 petitioner EX-1065 - webarchive of Chemical Database for Ustekinumab Download
Nov 22, 2023 1066 petitioner EX-1066 - webarchive of Label: STELARA - ustekinumab injection, solution Download
Nov 22, 2023 1067 petitioner EX-1067 - Webarchive of Label: STELARA - ustekinumab injection, solution Download
Nov 22, 2023 1068 petitioner EX-1068 - Labeling Archives, search results for ustekinumab - 2016 STELARA Download
Nov 22, 2023 1069 petitioner EX-1069 STELARA- ustekinumab solution Archived Drug Label )Sept. 2016) Download
Nov 22, 2023 1070 petitioner EX-1070 - Ustekinumab (Stelara), Ottawa (ON): Canadian Agency for Drugs... Download
Nov 22, 2023 1071 petitioner EX-1071 - Declaration of Noah S. Frank Download
Nov 22, 2023 1072 petitioner EX-1072 - Listing of Challenged Claims of the 10,961,307 patent Download
Nov 22, 2023 2 petitioner IPR Petition (307) Download
Nov 22, 2023 1014 petitioner EX-1014 - Aggeletopoulou et al., Interleukin 12/interleukin 23 pathway... Download
Nov 22, 2023 1013 petitioner EX-1013 - Yen et al., IL-23 is essential for T cell-mediated colitis and... Download
Nov 22, 2023 1012 petitioner EX-1012 - Uhlig et al., Differential Activity of IL-12 and IL-23... Download
Nov 22, 2023 1011 petitioner Exhibit 1011 - Ahern et al., Interleukin-23 Drives Intestinal Inflammation. Download
Nov 22, 2023 1010 petitioner Download
Nov 22, 2023 1009 petitioner EX-1009 - Danese & Fiocchi, Ulcerative Colitis, N Engl J Med., 365:1713- 25 Download
Nov 22, 2023 1008 petitioner Download
Nov 22, 2023 1007 petitioner EX-1007 - Adalimumab label Humira Download
Nov 22, 2023 1006 petitioner EX-1006 - Vedolizumab label Entyvio_VMB245 R1_FULL INFORMATION_300 mg_2014 Download
Nov 22, 2023 1005 petitioner EX-1005 - Updated Ochsenkuhn JCC Abstract Download
Nov 22, 2023 1004 petitioner EX-1004 - 2017.02.25 Internet Archives - Stelara label 761044lbl Download
Nov 22, 2023 1003 petitioner Download
Nov 22, 2023 1002 petitioner Ex-1002-Declaration of Alan Victor Safdi Download
Nov 22, 2023 1001 petitioner EX-1001 - U.S. Patent 10.961,307 Download
Nov 22, 2023 1044 petitioner EX-1044 - Glossary of Common Site Terms, ClinicalTrials.gov (Oct. 2021) Download
Menu